Search clinical trials for: 24 hour magnesuria

Total 6566 results

Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil in Subjects With Mild to Moderate Hypertension

Hypertension

United States
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Impotence

Korea, Republic of
Eli Lilly and Company
ICOS Corporation

Completed

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Impotence

China
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Impotence

Germany
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Impotence

Japan
Eli Lilly and Company
ICOS Corporation

Completed

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Impotence

Sweden
Eli Lilly and Company
ICOS Corporation

Completed

Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

Impotence

United Kingdom
Eli Lilly and Company
ICOS Corporation

Completed

Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

Impotence

Brazil
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems (PILUTS)

Prostatic Hyperplasia | Prostate

United States
Eli Lilly and Company

Completed

Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

Pancreatic Neoplasms

France
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Anxiety Disorder

Argentina, Australia, Belgium, Canada, Mexico, Russian Federation, Taiwan, United Kingdom
German Breast Group

Completed

German Preoperative Adriamycin Docetaxel Study

Breast Neoplasms
Eli Lilly and Company

Completed

A Study of the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Post-Menopausal

China
Eli Lilly and Company

Completed

PTH Comparison in Post Menopausal Women

Osteoporosis, Post-Menopausal

Taiwan
Eli Lilly and Company

Completed

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Korea, Republic of
Eli Lilly and Company

Completed

Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion

Sepsis | Hypotension

France, United States
Eli Lilly and Company

Completed

Effects of Teriparatide on Distal Radius Fracture Healing

Colles' Fracture

Romania, Mexico, Sweden, United States, Poland
Mount Sinai Hospital, Canada
Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Canadian Foundation...

Completed

A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV

HIV Infections

Canada
Eli Lilly and Company

Completed

Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

Osteoporosis, Post-Menopausal

Puerto Rico
Eli Lilly and Company

Completed

Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Post-Menopausal

Russian Federation
Eli Lilly and Company

Completed

Long Term Effects of Raloxifene Treatment on Bone Quality

Osteoporosis, Post-Menopausal

United States, Mexico, Netherlands, Spain
Eli Lilly and Company

Completed

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Osteoporosis, Post-Menopausal

United States
National Institute of Allergy and Infectious Diseases...

Completed

Strategies for Delivering Anti-HIV Therapy in South Africa

HIV Infections

South Africa
Eli Lilly and Company

Completed

A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease

Breast Cancer | Breast Neoplasms | Cancer of the Breast

United States
Eli Lilly and Company

Completed

A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer

Breast Cancer

Egypt
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder

Anxiety Disorders

United States, Austria, France, Germany, Netherlands, Portugal, Puerto Rico
University of Giessen
Sanofi

Completed

Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes (ClampHOE901)

Diabetes

Germany
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Versus Placebo in the Treatment of FMS

Fibromyalgia

United States, Spain, Puerto Rico, Germany, United Kingdom, Sweden
Retina Associates, Kansas City
Genentech, Inc.

Unknown

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Proliferative Diabetic Retinopathy

United States
Eli Lilly and Company

Completed

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Diabetic Neuropathy, Painful

United States, Puerto Rico
Eli Lilly and Company

Completed

Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Depression

United States
Brigham and Women's Hospital
Schering-Plough

Terminated

Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

Angioplasty

United States
Eli Lilly and Company

Completed

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

Parkinson Disease

Italy, France, Belgium, Germany
Eli Lilly and Company

Completed

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

Germany
Eli Lilly and Company

Completed

Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression

Depression

Austria
Eli Lilly and Company

Completed

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Type 2 Diabetes Mellitus

United States, Spain, United Kingdom
Eli Lilly and Company

Completed

Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer

Bladder Cancer

Poland
Eli Lilly and Company

Completed

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

Bladder Neoplasms

Italy
Eli Lilly and Company

Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Non-Small Cell Lung Cancer

Poland
Eli Lilly and Company

Completed

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Spain
Eli Lilly and Company

Completed

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Slovakia
Eli Lilly and Company

Completed

Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic

Pancreatic Cancer

Germany
Eli Lilly and Company

Completed

Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

Biliary Tract Carcinoma

Korea, Republic of
Eli Lilly and Company

Completed

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

Hypopituitarism

United States, France, Germany, Italy, Puerto Rico, United Kingdom
Eli Lilly and Company

Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Non-Small Cell Lung Cancer

Germany, Italy, United Kingdom
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

Schizophrenic Disorders

Turkey, Finland

3

Subscribe